Hylke de Jonge

2.2k total citations
31 papers, 1.8k citations indexed

About

Hylke de Jonge is a scholar working on Pediatrics, Perinatology and Child Health, Transplantation and Pharmacology. According to data from OpenAlex, Hylke de Jonge has authored 31 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pediatrics, Perinatology and Child Health, 23 papers in Transplantation and 10 papers in Pharmacology. Recurrent topics in Hylke de Jonge's work include Renal Transplantation Outcomes and Treatments (23 papers), Pharmacological Effects and Toxicity Studies (23 papers) and Pharmacogenetics and Drug Metabolism (8 papers). Hylke de Jonge is often cited by papers focused on Renal Transplantation Outcomes and Treatments (23 papers), Pharmacological Effects and Toxicity Studies (23 papers) and Pharmacogenetics and Drug Metabolism (8 papers). Hylke de Jonge collaborates with scholars based in Belgium, United States and Sweden. Hylke de Jonge's co-authors include Dirk Kuypers, Maarten Naesens, Yves Vanrenterghem, Kristin Verbeke, Henriëtte de Loor, Evelyne Lerut, Bert Bammens, Kathleen Claes, Pieter Evenepoel and Christoph Metalidis and has published in prestigious journals such as New England Journal of Medicine, Journal of the American Society of Nephrology and Transplantation.

In The Last Decade

Hylke de Jonge

31 papers receiving 1.7k citations

Peers

Countries citing papers authored by Hylke de Jonge

Since Specialization

Citations

This map shows the geographic impact of Hylke de Jonge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hylke de Jonge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hylke de Jonge more than expected).

Fields of papers citing papers by Hylke de Jonge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hylke de Jonge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hylke de Jonge. The network helps show where Hylke de Jonge may publish in the future.

Co-authorship network of co-authors of Hylke de Jonge

This figure shows the co-authorship network connecting the top 25 collaborators of Hylke de Jonge. A scholar is included among the top collaborators of Hylke de Jonge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hylke de Jonge. Hylke de Jonge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Relationship between In Vivo CYP3A4 Activity, CYP3A5 Genotype, and Systemic Tacrolimus Metabolite/Parent Drug Ratio in Renal Transplant Recipients and Healthy Volunteers 2018 ·Drug Metabolism and Disposition ·Thomas Vanhove, Hylke de Jonge, Henriëtte de Loor, (unknown), Jan de Hoon, Anton Pohanka, Pieter Annaert, Dirk Kuypers	17
2	Rhodococcus equi Sepsis in a Renal Transplant Recipient 2015 ·Transplantation Direct ·(unknown), Hylke de Jonge, (unknown), Jan Verhaegen, (unknown), Eric Van Wijngaerden, Dirk Kuypers	6
3	The CYP3A422 C>T single nucleotide polymorphism is associated with reduced midazolam and tacrolimus clearance in stable renal allograft recipients 2014 ·The Pharmacogenomics Journal* ·Hylke de Jonge, Laure Elens, Henriëtte de Loor, Ron HN van Schaik, Dirk Kuypers	44
4	Intrarenal Resistive Index after Renal Transplantation 2013 ·New England Journal of Medicine ·Maarten Naesens, Line Heylen, Evelyne Lerut, Kathleen Claes, Liesbeth De Wever, Filip Claus, Raymond Oyen, Dirk Kuypers, Pieter Evenepoel, Bert Bammens, Ben Sprangers, Björn Meijers, Jacques Pirenne, Diethard Monbaliu, Hylke de Jonge, Christoph Metalidis, Katrien De Vusser, Yves Vanrenterghem	142
5	In Vivo CYP3A4 Activity, CYP3A5 Genotype, and Hematocrit Predict Tacrolimus Dose Requirements and Clearance in Renal Transplant Patients 2012 ·Clinical Pharmacology & Therapeutics ·Hylke de Jonge, Henriëtte de Loor, Kristin Verbeke, Yves Vanrenterghem, Dirk Kuypers	94
6	The Once-Daily Formulation of Tacrolimus 2012 ·Transplantation ·Jean‐Michel Hougardy, Hylke de Jonge, Dirk Kuypers, Daniel Abramowicz	21
7	Cutaneous phaeohyphomycosis in renal allograft recipients: report of 2 cases and review of the literature 2010 ·Diagnostic Microbiology and Infectious Disease ·Séverine Vermeire, Hylke de Jonge, Katrien Lagrou, Dirk Kuypers	33
8	Apparent Elevation of Cyclosporine Whole Blood Concentrations in a Renal Allograft Recipient 2010 ·Therapeutic Drug Monitoring ·Hylke de Jonge, (unknown), Peter Declercq, Henriëtte de Loor, Kathleen Claes, Koen Desmet, Dirk Kuypers	7
9	A prospective, open-label, observational clinical cohort study of the association between delayed renal allograft function, tacrolimus exposure, and CYP3A5 genotype in adult recipients 2010 ·Clinical Therapeutics ·Dirk Kuypers, Hylke de Jonge, Maarten Naesens, Yves Vanrenterghem	39
10	Tacrolimus Dose Requirements and CYP3A5 Genotype and the Development of Calcineurin Inhibitor-Associated Nephrotoxicity in Renal Allograft Recipients 2010 ·Therapeutic Drug Monitoring ·Dirk Kuypers, Maarten Naesens, Hylke de Jonge, Evelyne Lerut, Kristin Verbeke, Yves Vanrenterghem	95
11	The Pregnane X Receptor (NR1I2) C-25385T Single Nucleotide Polymorphism (SNP) Does Not Affect Tacrolimus Pharmacokinetics in a Large Cohort of Renal Transplant Recipients 2009 ·American Journal of Transplantation ·Hylke de Jonge, Maarten Naesens, Yves Vanrenterghem, Dirk Kuypers	1
12	New Insights Into the Pharmacokinetics and Pharmacodynamics of the Calcineurin Inhibitors and Mycophenolic Acid: Possible Consequences for Therapeutic Drug Monitoring in Solid Organ Transplantation 2009 ·Therapeutic Drug Monitoring ·Hylke de Jonge, Maarten Naesens, Dirk Kuypers	125
13	Donor Age and P-glycoprotein Determine Chronic Histological Damage Progression in Renal Allografts 2009 ·American Journal of Transplantation ·Maarten Naesens, Evelyne Lerut, Hylke de Jonge, Boudewijn Van Damme, Yves Vanrenterghem, Dirk Kuypers	1
14	Donor Age and Renal P-Glycoprotein Expression Associate with Chronic Histological Damage in Renal Allografts 2009 ·Journal of the American Society of Nephrology ·Maarten Naesens, Evelyne Lerut, Hylke de Jonge, Boudewijn Van Damme, Yves Vanrenterghem, Dirk Kuypers	114
15	Recovery of Hyperphosphatoninism and Renal Phosphorus Wasting One Year after Successful Renal Transplantation 2008 ·Clinical Journal of the American Society of Nephrology ·Pieter Evenepoel, Björn Meijers, Hylke de Jonge, Maarten Naesens, Bert Bammens, Kathleen Claes, Dirk Kuypers, Yves Vanrenterghem	118
16	Current target ranges of mycophenolic acid exposure and drug-related adverse events: A 5-year, open-label, prospective, clinical follow-up study in renal allograft recipients 2008 ·Clinical Therapeutics ·Dirk Kuypers, Hylke de Jonge, Maarten Naesens, Henriëtte de Loor, (unknown), (unknown), Yves Vanrenterghem	90
17	Pharmacogenetics in solid organ transplantation: current status and future directions 2007 ·Transplantation Reviews ·Hylke de Jonge, Dirk Kuypers	57
18	CYP3A5 and CYP3A4 but not MDR1 Single-nucleotide Polymorphisms Determine Long-term Tacrolimus Disposition and Drug-related Nephrotoxicity in Renal Recipients 2007 ·Clinical Pharmacology & Therapeutics ·Dirk Kuypers, Hylke de Jonge, Maarten Naesens, Evelyne Lerut, Kristin Verbeke, Yves Vanrenterghem	180
19	Aristolochic acid: the common culprit of Chinese herbs nephropathy and Balkan endemic nephropathy 2007 ·Nephrology Dialysis Transplantation ·Hylke de Jonge, Yves Vanrenterghem	38
20	Comparison of peritoneal dialysis and haemodialysis after renal transplant failure 2006 ·Nephrology Dialysis Transplantation ·Hylke de Jonge, Bert Bammens, Wim Lemahieu, Bart Maes, Yves Vanrenterghem	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact